Copyright
©2009 Baishideng Publishing Group Co.
World J Cardiol. Dec 31, 2009; 1(1): 46-50
Published online Dec 31, 2009. doi: 10.4330/wjc.v1.i1.46
Published online Dec 31, 2009. doi: 10.4330/wjc.v1.i1.46
Table 1 Demographic, clinical and TCL data n (%)
| IHD group | Control group | |
| Males | 41 | 9 |
| Females | 13 | 2 |
| Age (yr) | 63 ± 5 | 57 ± 3 |
| Previous M.I. | 47 (87) | 0 |
| Previous ACBG | 19 (35.2) | 0 |
| Previous PCI | 35 (64.8) | 0 |
| Diabetes | 15 (27.7) | 0 |
| Hypertension | 31 (57.4) | 0 |
| Current Smokers | 9 (16.6) | 3 (27.3) |
| Dyslipidemia | 34 (62.9) | 0 |
| S-T depression > 1 mmHg | 21 (38.8) | 0 |
| METS | 6.4 ± 0.5 | 10.9 ± 0.6 |
| Exercise duration (min) | 6.5 ± 0.8 | 11.2 ± 1.1 |
| Max Systolic BP (mmHg) | 137 ± 11 | 178 ± 10 |
| Max HR (bpm) | 133 ± 9 | 159 ± 11 |
| EF% < 40 | 28 (51.8) | 0 |
| EF% > 40 | 26 (48.2) | 0 |
| Normal EF% (> 55%) | 4 | 11 |
| F.C. I-II | 39 (72.2) | 0 |
| F.C. III | 15 (27.8) | 0 |
- Citation: Shanati A, Rivlin Y, Shnizer S, Rosenschein U, Goldhammer E. Serum oxidizability potential of ischemic heart disease patients is associated with exercise test results and disease severity. World J Cardiol 2009; 1(1): 46-50
- URL: https://www.wjgnet.com/1949-8462/full/v1/i1/46.htm
- DOI: https://dx.doi.org/10.4330/wjc.v1.i1.46